Modern Understanding of Central Serous Retinopathy (CSR)

The understanding of Central Serous Retinopathy (CSR), also known as Central Serous Chorioretinopathy (CSCR), has evolved significantly. It is now recognised as a multifactorial disease involving the choroid, retinal pigment epithelium (RPE), hormonal pathways, vascular regulation and inflammatory mechanisms, rather than simply a retinal fluid leak.

1. Choroidal Hyperpermeability: The Key Mechanism

Advances in retinal imaging, particularly Enhanced Depth Imaging OCT (EDI-OCT) and Indocyanine Green Angiography (ICGA), have highlighted the importance of the choroid in CSR.

Common findings include:

• Thickened choroid (pachychoroid) in many patients

• Enlargement of deeper choroidal vessels, particularly Haller's layer vessels

• Increased choroidal vascular congestion and permeability

• Stress on the overlying retinal pigment epithelium (RPE)

This has led to CSR being considered part of the pachychoroid spectrum, which includes pachychoroid pigment epitheliopathy, central serous chorioretinopathy, pachychoroid neovasculopathy and polypoidal choroidal vasculopathy.

2. Retinal Pigment Epithelium (RPE) Dysfunction

The RPE plays a vital role in maintaining the barrier between the retina and choroid and regulating fluid movement.

In CSR:

·       RPE pump function becomes impaired.

·       Focal RPE disruption allows fluid to accumulate beneath the retina.

·       Persistent RPE dysfunction may lead to retinal damage and lasting visual changes.

The leakage points seen on fluorescein angiography represent areas of RPE barrier breakdown.

3. The Pachychoroid Concept: A Change in Thinking

CSR was previously viewed mainly as a retinal disorder. Current evidence suggests a disease pathway involving:

Choroidal vascular dysfunction → increased choroidal permeability → RPE dysfunction → subretinal fluid accumulation

This helps explain why many patients have:

·       Increased choroidal thickness

·       Dilated choroidal vessels

·       Changes in both eyes despite symptoms in one eye

·       Recurrent episodes

4. Hormonal and Stress Pathways

CSR has a recognised association with corticosteroids and stress-related hormonal changes.

Research suggests involvement of the hypothalamic–pituitary–adrenal (HPA) axis, with possible effects including:

• Increased cortisol activity

• Glucocorticoid receptor activation

• Altered choroidal vascular regulation

• Increased vascular permeability

Associations include:

• Corticosteroid use (tablets, injections, inhalers, nasal sprays and creams)

• Cushing's syndrome

• High stress states

• Sleep disturbances

Stress is considered a contributing factor rather than a single cause.

5. Inflammation, Oxidative Stress and Immune Pathways

Emerging research suggests that inflammation and oxidative stress may contribute to CSR development and chronicity.

Possible mechanisms include:

• Altered complement pathway activity

• Oxidative damage affecting RPE cells

• Inflammatory effects on choroidal blood vessels

These pathways may help explain why some patients develop persistent or recurrent disease.

6. Autonomic and Vascular Regulation

CSR has also been linked with altered sympathetic nervous system activity, which may influence:

• Choroidal blood flow

• Vascular autoregulation

• Choroidal permeability

Associations include:

• Sleep deprivation

• Obstructive sleep apnoea

• Hypertension

• Increased sympathetic activity

7. Genetic Susceptibility

Research suggests that some individuals may have an underlying genetic predisposition to CSR.

Potential influences include genes involved in:

• Complement regulation

• Vascular function

• Extracellular matrix structure

• Pachychoroid characteristics

Genetic factors may partly explain why some individuals develop CSR despite similar environmental triggers.

Summary

Modern understanding views CSR as a complex disorder of the choroid–RPE–retina interface, where vascular changes, hormonal influences, inflammation and genetic susceptibility interact to cause fluid accumulation beneath the retina.

This improved understanding has transformed CSR management, allowing retinal specialists to provide more personalised assessment and treatment based on disease characteristics, duration and risk of visual damage.